Wheatgrass-and-Aronia-Mixed Extract Suppresses Immunoglobulin E-Mediated Allergic Reactions In Vitro and In Vivo
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241511979 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ji-Hyun Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Jeonbuk National University Medical School, Jeonju-si 54907, Republic of Korea. Hauptthemen laut MEDLINE: Photinia, Hypersensitivity, Anti-Allergic Agents, Anaphylaxis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Institute for Advancement of Technology, Ministry of Small and Medium-sized Enterprises (SMEs), BK21FOUR 21st Century of Medical Science Creative Human Resource Development Center.
Abstract (Originalsprache)
Mast cells are an important component of immune responses. Immunoglobulin (Ig) E-sensitized mast cells release substances within minutes of allergen exposure, triggering allergic responses. Until now, numerous pharmacological effects of wheatgrass and aronia have been verified, but the effects of wheatgrass and aronia (TAAR)-mixed extract on allergic reactions have not been identified. Therefore, the aim of this study was to demonstrate the anti-allergic effect of TAAR extract on mast cell activation and cutaneous anaphylaxis. In this study, we investigated the anti-allergic effects and related mechanisms of TAAR extract in IgE-activated mast cells in vitro. We also assessed the ameliorating effect of TAAR extract on IgE-mediated passive cutaneous anaphylaxis mice in vivo. The TAAR extract significantly reduced the expression of β-hexosaminidase, histamine, and pro-inflammatory cytokines, which are mediators related to mast cell degranulation, via the regulation of various signaling pathways. The TAAR extract also regulated oxidative-stress-related factors through the Nrf2 signaling pathway. Additionally, treatment of TAAR extract to the passive cutaneous anaphylaxis mouse model improved ear thickness and local ear pigmentation. Taken together, our results suggest that TAAR extract is a potential candidate natural product to treat overall IgE-mediated allergic inflammation and oxidative-stress-related diseases by suppressing mast cell activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Jeonbuk National University Medical School, Jeonju-si 54907, Republic of Korea.
- Department of Korean Pharmacy, Woosuk University, Wanju-Gun, Samnye-eup 55338, Republic of Korea.
- Department of Health Administration, Kwangju Women's University, Kwangju 62396, Republic of Korea.
- Department of Oriental Pharmacy, College of Pharmacy, Wonkwang-Oriental Medicines Research Institute, Wonkwang University, Iksan 54538, Republic of Korea.
Förderung
- Korea Institute for Advancement of Technology
- Ministry of Small and Medium-sized Enterprises (SMEs)
- BK21FOUR 21st Century of Medical Science Creative Human Resource Development Center
- Jeonbuk National University
Zitieren
APA
Lee, J. H., Lim, J. Y., Jeon, Y. D., Yun, D. H., Lee, Y. M., & Kim, D. K. (2023). Wheatgrass-and-Aronia-Mixed Extract Suppresses Immunoglobulin E-Mediated Allergic Reactions In Vitro and In Vivo. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241511979
Vancouver
Lee JH, Lim JY, Jeon YD, Yun DH, Lee YM, Kim DK. Wheatgrass-and-Aronia-Mixed Extract Suppresses Immunoglobulin E-Mediated Allergic Reactions In Vitro and In Vivo. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241511979
BibTeX
@article{Lee2023,
author = {Lee, Ji-Hyun and Lim, Ji-Ye and Jeon, Yong-Deok and Yun, Dae-Ho and Lee, Young-Mi and Kim, Dae-Ki},
title = {Wheatgrass-and-Aronia-Mixed Extract Suppresses Immunoglobulin E-Mediated Allergic Reactions In Vitro and In Vivo},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241511979}
}
EUVIMED